Atyr Pharma, Inc. · NASDAQ:ATYR
The Vanguard Group reported a 5.23% stake in Atyr Pharma, Inc. (Schedule 13G)
Event Jun 30, 2025 · Filed Jul 29, 2025
The Vanguard Group reported a 5.23% stake in Atyr Pharma, Inc., 4,655,048 shares, as a passive investor on Jun 30, 2025. Filed Jul 29, 2025 (Schedule 13G).
- Stake
- 5.23%
- Shares
- 4,655,048
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| The Vanguard Group | 5.23% | 4,655,048 |
Source
Related
- Atyr Pharma, Inc.
- The Vanguard Group
- Atyr Pharma, Inc. shareholders
- Schedule 13G/A · The Vanguard Group · Mar 26, 2026
- Schedule 13G/A · Federated Hermes, Inc. · Oct 7, 2026
- Schedule 13G/A · FMR LLC · Aug 6, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 27, 2026
- Schedule 13G/A · Federated Hermes, Inc. · Jul 8, 2026
- Schedule 13G/A · FMR LLC · Jun 5, 2026